selegiline has been researched along with Adrenal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamontin, B; Llau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM; Tran, MA | 1 |
| Nagatsu, T; Naoi, M; Shibahara, K; Suzuki, H; Takahashi, T | 1 |
2 other study(ies) available for selegiline and Adrenal Cancer
| Article | Year |
|---|---|
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Diagnosis, Differential; Drug Interactions; Female; Fluoxetine; Humans; Hypertension; Parkinson Disease; Pheochromocytoma; Selegiline | 1993 |
Ganglioside GM1 causes expression of type B monoamine oxidase in a rat clonal pheochromocytoma cell line, PC12h.
Topics: Adrenal Gland Neoplasms; Animals; Cell Line; Clorgyline; G(M1) Ganglioside; G(M2) Ganglioside; Kinetics; Kynuramine; Monoamine Oxidase; Nerve Growth Factors; Pheochromocytoma; Rats; Selegiline | 1987 |